Page 134 - 南京医科大学自然版
P. 134

第44卷第8期
               ·1162 ·                           南 京    医 科 大 学 学         报                        2024年8月


                   chiatry,2022,27(6):2659-2673                 [41]SMITH M A,RICHEY HARRIS P L,SAYRE L M,et al.
             [27]WANG Y,HONG F,YANG S. Roles of nitric oxide in      Widespread peroxynitrite⁃mediated damage in Alzheimer’
                   brain ischemia and reperfusion[J]. Int J Mol Sci,2022,  s disease[J]. J Neurosci,1997,17(8):2653-2657
                   23(8):4243                                   [42]GUIVERNAU B,BONET J,VALLS⁃COMAMALA V,et
             [28]LAN G,WANG P,CHAN R B,et al. Astrocytic VEGFA:      al. Amyloid ⁃ β peptide nitrotyrosination stabilizes oligo⁃
                   an essential mediator in blood⁃brain⁃barrier disruption in  mers and enhances NMDAR⁃mediated toxicity[J]. J Neu⁃
                   Parkinson’s disease[J]. Glia,2022,70(2):337-353   rosci,2016,36(46):11693-11703
             [29]GU Y,ZHOU C,PIAO Z,et al. Cerebral edema after ische⁃  [43]CUI Z Q,HU X Y,YANG T,et al. TMEM16F may be a
                   mic stroke:pathophysiology and underlying mechanisms  new therapeutic target for Alzheimer’s disease[J]. Neu⁃
                  [J]. Front Neurosci,2022,16:988283                 ral Regen Res,2023,18(3):643-651
             [30]MEMARPOUR S,BEHESHTI F,BAGHCHEGHI Y,et         [44]KAWAMOTO E M,CARARO⁃LOPES M M,KINOSHITA
                   al. Neuronal nitric oxide inhibitor 7 ⁃ nitroindazole im⁃  P F,et al. Influence of nitric oxide⁃cyclic GMP and oxida⁃
                   proved brain⁃derived neurotrophic factor and attenuated  tive stress on amyloid⁃β peptide induced decrease of Na,
                   brain tissues oxidative damage and learning and memory  K⁃ATPase activity in rat hippocampal slices[J]. J Membr
                   impairments of hypothyroid juvenile rats[J]. Neurochem  Biol,2021,254(5⁃6):463-473
                   Res,2020,45(11):2775-2785                    [45]NAKAMURA T,TU S,AKHTAR M W,et al. Aberrant
             [31]COLUCCI⁃D’AMATO L,SPERANZA L,VOLPICELLI F.          protein s⁃nitrosylation in neurodegenerative diseases[J].
                   Neurotrophic factor BDNF,physiological functions and  Neuron,2013,78(4):596-614
                   therapeutic potential in depression,neurodegeneration  [46]MARTINS⁃PINGE M C,DE JAGER L,DE CAMPOS B
                   and brain cancer[J]. Int J Mol Sci,2020,21(20):7777  H,et al. Nitric oxide involvement in cardiovascular dys⁃
             [32]CANOSSA M,GIORDANO E,CAPPELLO S,et al. Nitric       functions of parkinson disease[J]. Front Pharmacol,
                   oxide down⁃regulates brain⁃derived neurotrophic factor se⁃  2022,13:898797
                   cretion in cultured hippocampal neurons[J]. Proc Natl  [47]EVE D J,NISBET A P,KINGSBURY A E,et al. Basal
                   Acad Sci U S A,2002,99(5):3282-3287               ganglia neuronal nitric oxide synthase mRNA expression
             [33]FICIARÀ E,STURA I,GUIOT C. Iron deposition in brain:  in Parkinson’s disease[J]. Mol Brain Res,1998,63(1):
                   Does aging matter?[J]. Int J Mol Sci,2022,23(17):  62-71
                   10018                                        [48]KNOTT C,STERN G,WILKIN G P. Inflammatory regula⁃
             [34]KIM Y,CONNOR J R. The roles of iron and HFE geno⁃   tors in Parkinson’s disease:iNOS,lipocortin⁃1,and cyclo⁃
                   type in neurological diseases[J]. Mol Aspects Med,2020,  oxygenases⁃1 and ⁃2[J]. Mol Cell Neurosci,2000,16(6):
                   75:100867                                         724-739
             [35]LIU C,LIANG M C,SOONG T W. Nitric oxide,iron and  [49]HANCOCK D B,MARTIN E R,VANCE J M,et al. Nitric
                   neurodegeneration[J]. Front Neurosci,2019,13:114  oxide synthase genes and their interactions with environ⁃
             [36]KHAN S,BARVE K H,KUMAR M S. Recent advance⁃         mental factors in Parkinson’s disease[J]. Neurogenetics,
                   ments in pathogenesis ,diagnostics and treatment of  2008,9(4):249-262
                   Alzheimer’s disease[J]. Curr Neuropharmacol,2020,18  [50]GÜZELAD Ö,ÖZKAN A,PARLAK H,et al. Protective
                  (11):1106-1125                                     mechanism of syringic acid in an experimental model of
             [37]ANON. 2023 Alzheimer’s disease facts and figures[J].  Parkinson’s disease[J]. Metab Brain Dis,2021,36(5):
                   Alzheimers Dement,2023,19(4):1598-1695            1003-1014
             [38]DE LA MONTE S M,JHAVERI A,MARON B A,et al.     [51]KOCAK Y,OTO G,HUYUT Z,et al. Effects of fluoride
                   Nitric oxide synthase 3⁃mediated neurodegeneration after  on oxidative DNA damage,nitric oxide level,lipid peroxi⁃
                   intracerebral gene delivery[J]. J Neuropathol Exp Neu⁃  dation and cholinesterase enzyme activity in a rotenone⁃
                   rol,2007,66(4):272-283                            induced experimental Parkinson’s model[J]. Neurol Res,
             [39]KUMMER M P ,HERMES M ,DELEKARTE A ,et al.           2023,45(11):979-987
                   Nitration of tyrosine 10 critically enhances amyloid β ag⁃  [52]CUI X,LI M,HE Z,et al. MiR⁃302b⁃5p enhances the neu⁃
                   gregation and plaque formation[J]. Neuron,2011,71(5):  roprotective effect of IGF⁃1 in methyl⁃4⁃phenyl⁃1,2,3,6⁃
                   833-844                                           tetrahydropyridine⁃induced Parkinson’s disease by regu⁃
             [40]HORIGUCHI T,URYU K,GIASSON B I,et al. Nitration     lating inducible nitric ⁃ oxide synthase[J]. Cell Biochem
                   of tau protein is linked to neurodegeneration in tauopa⁃  Funct,2020,38(8):1025-1035
                   thies[J]. Am J Pathol,2003,163(3):1021-1031  [53]HU X L,LV X Y,WANG R,et al. Optimization of of N⁃
   129   130   131   132   133   134   135   136   137   138   139